// App-Quantinova.ai

3953 : Highly accurate genetic profiling of circulating tumor cells using a label-free inertial microfluidic approach coupled with droplet PCR-based next-generation sequencing

Researchers

Presenter

  • Yi Fang Lee

Principal Investigators

  • Mark Consugar

  • Kimberly Helzer

  • Mei Hui Tan

  • Lori Emrick

  • Ali Asgar Bhagat

Medical Centers

  • Clearbridge Biomedics Pte Ltd, Singapore, Singapore

  • Raindance Technologies, Inc, Billerica, MA.

Locations

  • United States

  • Singapore

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

Biomarkers

  • Circulating tumor cells

  • Cyclin Dependent Kinase Inhibitor 2A

  • Epidermal growth factor receptor

  • Tumor protein p53

Drug/Treatment

  • TP53

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved